Brooklyn ImmunoTherapeutics, Inc.·4

Jan 19, 9:46 PM ET

Redman Heather B 4

4 · Brooklyn ImmunoTherapeutics, Inc. · Filed Jan 19, 2022

Insider Transaction Report

Form 4
Period: 2022-01-14
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-14+67,00067,000 total
    Exercise: $3.22Exp: 2032-01-14Common Stock, par value $0.005 per share (67,000 underlying)
Footnotes (1)
  • [F1]The stock option vests (subject to continued service) with respect to 22,336 shares of common stock on the first anniversary of the grant date and then in subsequent monthly installments of 1,861 shares of common stock through the three-year anniversary of the grant date.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4